InvestorsHub Logo
Followers 81
Posts 3648
Boards Moderated 0
Alias Born 02/15/2010

Re: stealthways post# 24226

Wednesday, 10/14/2015 9:18:29 PM

Wednesday, October 14, 2015 9:18:29 PM

Post# of 466127
From 2013, more on pre-clinical and Anavex Life Sciences Corp. (AVXL.OB) Comments on FDA Plan to Expedite Approval of New Alzheimer's Drugs

As reported by the New York Times, drugs in clinical trials would qualify for approval if people with very early-stage Alzheimer's showed even subtle improvement in memory or reasoning tests. ANAVEX 2-73, the company's lead compound for Alzheimer's disease, has successfully completed a Phase 1 clinical trial in humans.

http://www.biospace.com/News/anavex-life-sciences-corp-comments-on-fda-plan-to/290821


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News